Royalty Pharma Plc (RPRX NASDAQ) stock market data APIs
$37.2238
-0.63(-1.7%)
as of October 17, 2025
Try our APIs with
free plan!
Royalty Pharma Plc Financial Data Overview
Price chart is built with
Anychart
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Prev. Close
37.2238
Open
36.5897
High
36.8892
Low
36.3199
52 wk Range
23.5895-37.965
Market Cap
21 583 M
P/E Ratio
16.1616
Shares Outstanding
432 M
Revenue
2 305 M
EPS
1.14
Dividends (Yield)
0.0237
Beta
0.587
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Royalty Pharma Plc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Royalty Pharma Plc data using free add-ons & libraries
Get Royalty Pharma Plc Fundamental Data
Royalty Pharma Plc Fundamental data includes:
- Net Revenue: 2 305 M
- EBITDA: 1 498 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: 1.03
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Royalty Pharma Plc News
New
Praxis Precision Medicines (PRAX) Surges 183.7%: Is This an Indication of Further Gains?
Praxis Precision Medicines, Inc. (PRAX) shares rallied 183.7% in the last trading session to close at $162.71. This move can be attributable to notable volume with a higher number of shares being trad...
Royalty Pharma declares $0.22 dividend
* Royalty Pharma (NASDAQ:RPRX [https://seekingalpha.com/symbol/RPRX]) declares $0.22/share quarterly dividend [https://seekingalpha.com/pr/20270270-royalty-pharma-declares-fourth-quarter-2025-divide...
Royalty Pharma Declares Fourth Quarter 2025 Dividend
NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2025 of $0.22 per Class A ord...
Royalty Pharma Declares Fourth Quarter 2025 Dividend
Royalty Pharma plc NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2025 of $0....
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
